peptidesinstitute.org
GROWTH/STRENGTH

Ipamorelin

Ipamorelin (Selective GHRP-5)

Selective Growth Hormone Releasing Peptide for Strength

Buy Ipamorelin
Overview

What is Ipamorelin?

Ipamorelin is a selective growth hormone releasing peptide (GHRP) that stimulates the pituitary gland to produce and release growth hormone (GH). It is a pentapeptide (five amino acids) that acts as a ghrelin/growth hormone secretagogue receptor agonist, triggering the natural pulsatile release of growth hormone.

What makes ipamorelin unique among growth hormone releasing peptides is its selectivity. Unlike other GHRPs such as GHRP-6 or GHRP-2, ipamorelin does not significantly increase cortisol, prolactin, or appetite. This selectivity makes it one of the safest and most well-tolerated growth hormone peptides available.

Ipamorelin promotes lean muscle growth, enhances fat metabolism, improves recovery from exercise and injury, strengthens bones, and supports better sleep quality. It works synergistically with growth hormone releasing hormones (GHRH) like CJC-1295, and the two are often used together for enhanced results.

The growth hormone release from ipamorelin follows a natural pulsatile pattern, which helps maintain the body's normal hormonal feedback mechanisms and reduces the risk of desensitization that can occur with continuous GH stimulation.

Research Supply

Source high-purity Ipamorelin for your research

Protocol

Dosage Guide

Route: Subcutaneous injection, 2-3 times daily

Dosing Schedule

PeriodDose
Standard200-300 mcg per injection, 2-3 times daily
Beginner100-200 mcg per injection, 2 times daily
Advanced300 mcg per injection, 3 times daily

Reconstitution

VIAL SIZE5 mg (5000 mcg)
WATER VOLUME2 mL
CONCENTRATION2500 mcg/mL
Each 0.1 mL (10 units on a U-100 insulin syringe) = 250 mcg

Injection Volumes

DoseVolumeSyringe Units
100 mcg0.04 mL4 units
200 mcg0.08 mL8 units
250 mcg0.1 mL10 units
300 mcg0.12 mL12 units

Cycling Protocol

ON PERIOD

8-12 weeks

OFF PERIOD

4 weeks

Cycle to prevent receptor desensitization. Repeat as needed.

Administration Tips

  • Inject subcutaneously in the abdomen, thigh, or upper arm
  • Do not eat for at least 30 minutes before and after injection (food, especially carbs and fats, can blunt GH release)
  • Rotate injection sites
  • Store reconstituted solution refrigerated and use within 28 days
  • Optimal timing: morning upon waking, post-workout, and 30-60 minutes before sleep
Safety

Risks & Side Effects

Commonly Reported

Headache (most common, usually mild)Injection site redness or irritationMild dizzinessFlushingWater retention (mild)Tingling or numbness in extremities

Serious Risks

Carpal tunnel syndrome

From elevated GH levels; usually dose-dependent.

Joint pain

Particularly at higher doses.

Insulin resistance

With prolonged high-dose use.

Allergic reactions

Rare; discontinue if swelling or difficulty breathing occurs.

FAQ

Frequently Asked Questions

Related Research
Expert Voices

Experts Covering Ipamorelin

LEGAL DISCLAIMER

The information provided on this page is for educational and informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional before starting any peptide therapy. Individual results may vary. Peptides Institute is not responsible for any adverse effects resulting from the use of information provided on this site.